跳至主要内容
临床试验/NCT04720040
NCT04720040已完成不适用

Using YMS-201B in Patients With Mild to Moderate Major Depressive Disorder To Evaluate Efficacy and Safety for the Effect of Improving Depressive Symptoms Open, Single-group, Multicenter Confirmatory Clinical Trial

Ybrain Inc.2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2019年12月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Ybrain Inc.
入组人数
65
试验地点
2
主要终点
Korean-Beck Depression Inventory-II

研究概览

简要总结

This study evaluated the effectiveness and safety of improving depressive symptoms by applying tDCS for 6 weeks to patients with mild to moderate depression.

详细描述

Patients received tDCS for 30 minutes with an intensity of 1.5 to 2 mA. tDCS was applied over the left (anode) and right (cathode) dorsolateral prefrontal cortex (DLPFC) 5~7 times a week and they were evaluated every 2weeks through questionnaires.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has a diagnosis of a major depressive disorder as confirmed by the DSM-V and MINI (without psychotic features)
  • Patients with a K-BDI-II score of 14 or more and 28 or less
  • In the case of patients who have previously administered antidepressants, antipsychotics, and anticonvulsants for at least 1 week, Patients with sufficient drug treatment periods of at least 5 times the drug half-life.

排除标准

  • Patients diagnosed with Axis I disorders other than major depressive disorder
  • Patients diagnosed with other depressive disorders besides major depressive disorder
  • Patients who have attempted suicide within 6 months of screening
  • Patients who are considered to have problems with EEG and DC stimulation electrode attachment due to scalp deformity, inflammatory reaction, or other dermatological problems
  • Patients judged to have other reasons for prohibition of use of tDCS medical devices
  • Patients currently taking antidepressants

结局指标

主要结局

Korean-Beck Depression Inventory-II

时间窗: At 6 weeks after treatment.

Average change of K-BDI-II at 6 weeks after treatment compare to the base respectively. This scale contains 21 questions, each answer being scored on a scale value of 0 to 3. Higher total scores indicate more severe depressive symptoms.The lower the total score, the better the symptoms.

次要结局

  • Korean-Beck Anxiety Depression Inventory(Weeks 0, 2, 4, and 6)
  • Hamilton Rating Scale for Depression(Weeks 0, 2, 4, and 6)

研究者

发起方
Ybrain Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

The Efficacy and Safety of tDCS in Patients With... | 临床试验